BrightSpring Health Services, Inc. (BTSG)
(Delayed Data from NSDQ)
$11.96 USD
+0.26 (2.22%)
Updated Jul 22, 2024 04:00 PM ET
2-Buy of 5 2
A Value B Growth D Momentum B VGM
Income Statements
Fiscal Year end for BrightSpring Health Services, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 8,826 | 7,721 | 6,698 | NA | NA |
Cost Of Goods | 7,392 | 6,366 | 5,450 | NA | NA |
Gross Profit | 1,434 | 1,354 | 1,248 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 1,287 | 1,166 | 1,014 | 0 | 0 |
Income After Depreciation & Amortization | 147 | 188 | 234 | 0 | 0 |
Non-Operating Income | 0 | 0 | 0 | NA | NA |
Interest Expense | 325 | 234 | 165 | NA | NA |
Pretax Income | -177 | -46 | 69 | NA | NA |
Income Taxes | -21 | 8 | 18 | NA | NA |
Minority Interest | -2 | 0 | 1 | NA | NA |
Investment Gains/Losses | 0 | 0 | 0 | NA | NA |
Other Income/Charges | 0 | 0 | 0 | NA | NA |
Income From Cont. Operations | -157 | -54 | 51 | NA | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | NA | NA |
Net Income (GAAP) | -155 | -54 | 50 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 370 | 453 | 454 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 223 | 265 | 220 | NA | NA |
Income After Depreciation & Amortization | 147 | 188 | 234 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 117.87 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.31 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.31 | NA | NA | NA | NA |
Fiscal Year end for BrightSpring Health Services, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 2,576.64 | 2,374.54 | NA | NA |
Cost Of Goods | NA | 2,207.25 | NA | NA | NA |
Gross Profit | NA | 369.39 | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 361.32 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 8.07 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | -12.73 | NA | NA | NA |
Interest Expense | NA | 65.02 | NA | NA | NA |
Pretax Income | NA | -69.68 | NA | NA | NA |
Income Taxes | NA | -23.29 | NA | NA | NA |
Minority Interest | NA | -0.64 | NA | NA | NA |
Investment Gains/Losses | NA | 0.00 | NA | NA | NA |
Other Income/Charges | NA | 0.00 | NA | NA | NA |
Income From Cont. Operations | NA | -46.39 | -6.54 | NA | NA |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | NA | NA |
Net Income (GAAP) | NA | -45.75 | -6.54 | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 175.53 | 117.86 | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | 0.12 | -0.06 | NA | NA |
Diluted Net EPS (GAAP) | NA | -0.26 | -0.06 | NA | NA |